Ligand · DT4
DT4 · 4-({5-[(4-aminocyclohexyl)amino][1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzenesulfonamide
DT4, 4-({5-[(4-aminocyclohexyl)amino][1,2,4]triazolo[1,5-a]pyrimidin-7-yl}amino)benzenesulfonamide (C17 H22 N8 O2 S, 402.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- DT4
- Formula
- C17 H22 N8 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
DT4 in 2 structures; the first of them:
- 2C6L · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT4 A1299 · binds ILE10, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64, PHE80 and 12 more
- 2C6L · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT4 A1299 · binds ILE10, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64, PHE80 and 12 more
Residues it binds most
LYS 2, ASP 2, GLN 2, GLU 2, LEU 2, PHE 2, VAL 2, ALA 2, ASN 2, GLY 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.